Stock picks from our team of market veterans.
Among all the companies that reported financial results last week, here are 3 “blue chips” that stood out.
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, explains why Morgans sees Sonic Healthcare Ltd (SHL) as a BUY.
Here are two mining services companies that are possibly flying under the radar, that could reward investigation right now.
Nearing only the half-way point of the current reporting season (in terms of numbers of corporate updates), for the week ending Friday 20 February 2026, FNArena recorded 32 upgrades and 16 downgrades across ASX-listed companies from brokers monitored daily.
Hedge funds and other short sellers have had a picnic dumping any stock where AI could possibly threaten the underlying business. But are we seeing a hijacking of great businesses by market 'terrorists' that we could make money out of?
Are bad times behind this leading global biotechnology company founded in Australia in 1916?
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, explains why Morgans maintains its BUY rating for Breville Group (BRG).
Here are three promising (though not yet profitable and speculative) companies trying to emulate that success of medical device companies such as Cochlear and RedMed.
For the week ending Friday, February 13, 2026, FNArena tracked 31 upgrades and 12 downgrades for ASX-listed companies from brokers monitored daily.
While Artificial Intelligence fears may drive software-as-a-service stocks below their real worth, index investing can still play a role.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.